Covaxin, a candidate for BHARAT BIOTECH’s indigenous Covid vaccine currently in late-stage clinical trials, triggered humoral and cell-mediated immune responses and was well tolerated with no serious adverse events in its phase 2 trials, according to an article by Research released by the Hyderabad-based company, which has yet to be …
Read More »
Covaxin can generate antibodies that can persist for 6 to 12 months, Bharat Biotech said. (Archive) Hyderabad: Covaxin, a COVID-19 vaccine developed by Bharat Biotech, showed long-term memory responses of antibodies and T (immune) cells three months after injection in phase 1 volunteers and tolerable safety results in phase 2 …
Read More »
Hyderabad-based Bharat Biotech has applied for the Emergency Use Authorization of its COVID-19 COVAXIN vaccine again with the Comptroller General of Drugs of India (DCGI), sources told News18 on Wednesday. COVAXIN, an inactivated candidate vaccine, is currently in phase III human clinical trials with 26,000 volunteers at 25 centers in …
Read More »
HYDERABAD: India’s first indigenous Covid-19 vaccine, Covaxin, has shown long-term antibody and T-cell memory responses three months after vaccination in phase I volunteers Covaxin can generate antibodies that can persist for 6 to 12 months, Bharat Biotech said in a research article. According to the document uploaded to ‘medRxiv’, a …
Read More »
According to the company, the vaccine is developed and manufactured at Bharat Biotech’s BSL-3 biocontainment facility. “This is an unprecedented vaccine trial to be conducted in India, and we are overwhelmed by the steady increase in participation. We sincerely thank all 13,000 volunteers across the country for their support in …
Read More »
Six passengers traveling on Air India’s London-Delhi flight tested positive for COVID-19 upon arrival, a senior government official said on December 22. Read also: Coronavirus, December 22 updates The flight landed around 11.30pm on December 21. “Five COVID-positive passengers were found at the Delhi airport. A passenger, who took a …
Read More »
The total number of recovered cases is more than 30 times the number of active cases, the ministry said. The number of confirmed COVID-19 cases in India surpassed the 1 crore (10 million) mark on December 18, 2020. According to the Center for Systems Science and Engineering (CSSE) at John …
Read More »
The total number of recovered cases is more than 30 times the number of active cases, the ministry said. The number of confirmed COVID-19 cases in India surpassed the 1 crore (10 million) mark on December 18, 2020. According to the Center for Systems Science and Engineering (CSSE) at John …
Read More »
ROHTAK: The condition of Haryana Health Minister Anil Vij, who is receiving treatment for COVID-19 at Medanta Hospital in Gurugram, is stable and his vital parameters are normal, said Dr. AK Dubey, Medical Superintendent of the hospital. “The Haryana Minister of Health is receiving treatment in the intensive care unit …
Read More »
The rejection rate of the phase 3 trial is much higher than that of the phase 1 and phase 2 trials, said Dr. Sanjay Rai. New Delhi: Although the phase 1 trial of its Covaxin vaccine obtained “encouraging” results, Hyderabad-based Bharat Biotech faces challenges in phase 3 trials of its …
Read More »